ES2097764T3 - Extracto de levadura insoluble. - Google Patents

Extracto de levadura insoluble.

Info

Publication number
ES2097764T3
ES2097764T3 ES90917227T ES90917227T ES2097764T3 ES 2097764 T3 ES2097764 T3 ES 2097764T3 ES 90917227 T ES90917227 T ES 90917227T ES 90917227 T ES90917227 T ES 90917227T ES 2097764 T3 ES2097764 T3 ES 2097764T3
Authority
ES
Spain
Prior art keywords
yeast extract
extracted
acid
production
insoluble yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90917227T
Other languages
English (en)
Inventor
Byron A Donzis
Joyce K Czop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23726692&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2097764(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2097764T3 publication Critical patent/ES2097764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE PRESENTA UN METODO PARA LA PRODUCCION DE UN EXTRACTO DE LEVADURA EN DONDE LAS CELULAS DE LEVADURA SON INICIALMENTE ESTERILIZADAS EN EL AUTOCLAVE ANTE LA PRESENCIA DE UNA SOLUCION ALCALINA. EL MATERIAL EXTRAIDO DE ALCALINO RESIDUAL SE EXTRAE ENTONCES CON UN ACIDO. A CONTINUACION SE LAVA EL RESIDUO EXTRAIDO DE ACIDO CON ETANOL. ESTE METODO PARA LA PRODUCCION DE UN EXTRACTO DE LEVADURA SE PUEDE LLEVAR A CABO EN UN PERIODO DE TIEMPO MUCHO MAS CORTO QUE SI SE UTILIZAN LOS METODOS YA CONOCIDOS, GENERALMENTE EN OCHO HORAS APROXIMADAMENTE. EL METODO DA COMO RESULTADO UN PRODUCTO DE GLUCANO QUE NO TIENE SUSTANCIALMENTE PROTEINAS Y QUE ES UN ESTIMULADOR POTENTE DE LA ACTIVIDAD MACROFAGA.
ES90917227T 1989-11-09 1990-11-02 Extracto de levadura insoluble. Expired - Lifetime ES2097764T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/435,032 US5223491A (en) 1989-11-09 1989-11-09 Method for revitalizing skin by applying topically water insoluble glucan

Publications (1)

Publication Number Publication Date
ES2097764T3 true ES2097764T3 (es) 1997-04-16

Family

ID=23726692

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90917227T Expired - Lifetime ES2097764T3 (es) 1989-11-09 1990-11-02 Extracto de levadura insoluble.

Country Status (7)

Country Link
US (2) US5223491A (es)
EP (1) EP0500718B1 (es)
JP (1) JPH05504131A (es)
CA (1) CA2072145C (es)
DE (1) DE69029860T2 (es)
ES (1) ES2097764T3 (es)
WO (1) WO1991007091A1 (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292513A (en) * 1992-05-18 1994-03-08 Anthony G. Gristina Method for nonspecific cellular immune stimulation
EP0595209A3 (en) * 1992-10-23 1996-07-17 R I T A Corp An Illinois Corp Cosmetic composition
FR2700470B1 (fr) * 1993-01-15 1995-02-17 Sederma Sa Nouvelles compositions cosmétiques contenant des bactéries inactivées et/ou des parois bactériennes et leur utilisation.
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
GB9403153D0 (en) * 1994-02-18 1994-04-06 Ciba Geigy Ag Cosmetic compositions
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
GB2331014C (en) * 1995-03-13 2005-06-21 Novogen Res Pty Ltd Therapeutic uses of glucan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening
JP3687194B2 (ja) * 1996-06-06 2005-08-24 味の素株式会社 水不溶性グルカンの精製方法
US5776441A (en) * 1996-08-30 1998-07-07 Avon Products, Inc. Lip treatment containing live yeast cell derivative
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
EP0875580A1 (en) * 1997-05-02 1998-11-04 Difass S.A. Process for obtaining polysaccharides from yeasts
DE19839216C1 (de) * 1998-08-28 2000-01-20 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von sphärischen Mikropartikeln, die ganz oder teilweise aus mindestens einem wasserunlöslichen Verzweigungen enthaltenden Polyglucan bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und die Verwendung
US6485945B1 (en) * 1999-02-17 2002-11-26 Nurture, Inc. Polysaccharide compositions and uses thereof
US6323338B1 (en) 1999-02-17 2001-11-27 Nurture, Inc. Method for concentrating β-glucan
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
AU3657100A (en) * 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
DE19911052A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sonnenschutzmittel
DE19917744A1 (de) 1999-04-20 2000-10-26 Cognis Deutschland Gmbh Dekorative kosmetische Zubereitungen
US6541678B2 (en) * 1999-09-27 2003-04-01 Brennen Medical, Inc. Immunostimulating coating for surgical devices
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
EP1267795A1 (en) * 2000-03-30 2003-01-02 Brennen Medical Inc. Anti-microbial and immunostimulating composition
JP3363438B2 (ja) * 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
WO2002012348A2 (en) * 2000-08-03 2002-02-14 Abac R & D Gmbh Isolation of glucan particles and uses thereof
US6476003B1 (en) 2000-11-06 2002-11-05 Immusonic, Inc. Method for preparing small particle size glucan in a dry material
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
US6790465B2 (en) 2000-12-01 2004-09-14 Snore-Fix, Inc. Composition and method for treating snoring
US7906492B2 (en) * 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7786094B2 (en) * 2001-10-09 2010-08-31 Biopolymer Engineering, Inc. Use of beta-glucans against biological warfare weapons and pathogens including anthrax
JP2005517419A (ja) * 2002-02-21 2005-06-16 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚の光防護に適するペットフード組成物
ES2297181T3 (es) * 2002-02-21 2008-05-01 Societe Des Produits Nestle S.A. Una composicion fotoprotectora para la piel, de administracion oral.
ES2263990T3 (es) * 2002-02-21 2006-12-16 Societe Des Produits Nestle S.A. Composicion oralmente administrable para la fotoproteccion de la piel.
JP2006507239A (ja) 2002-08-13 2006-03-02 バイオポリマー エンジニアリング，インコーポレイテッド 放射線防護剤としてのベータグルカンの使用方法
WO2004021994A2 (en) 2002-09-04 2004-03-18 Biopolymer Engineering, Inc. Cancer therapy using whole glucan particles and antibodies
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
CA2514544A1 (en) * 2003-01-29 2004-08-12 Immudyne, Inc. Immunopotentiating agent for use in animals
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
US20050020490A1 (en) * 2004-10-18 2005-01-27 Progressive Bioactives Incorporated A Method of Producing an Economical and Ecologically Sound Natural Immunobiotic Extract for Use as a Health Management Instrument and a Replacement for Growth Promotion Antibiotics in Livestock and Companion Animals.
US20090092641A1 (en) * 2004-10-18 2009-04-09 Progressive Bioactivities, Inc. Uses of natural immunobiotic extract
BRPI0611535B1 (pt) 2005-05-05 2021-11-30 Sensient Flavors Inc Método para processar células de levedura para produzir beta-glucanos e mananas
EP1896601A1 (en) * 2005-06-15 2008-03-12 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
EP1896600A2 (en) 2005-06-15 2008-03-12 Medimush A/S Anti-cancer combination treatment and kit-of-part
KR100832387B1 (ko) * 2005-12-02 2008-05-26 주식회사 글루칸 β-glucan을 유효성분으로 포함하는 창상 및 피부염 치료용 약학적 조성물
US20090053221A1 (en) * 2006-01-17 2009-02-26 Cheung Nai-Kong V Immune response enhancing glucan
US8323644B2 (en) * 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
BRPI0713734A2 (pt) * 2006-06-15 2012-11-06 Biopolymer Engineering Inc Dba Biothera processo para a produção de beta-glucano solúvel, e, composição
EP2062588A4 (en) * 2006-08-24 2011-06-08 Kirin Holdings Kk COMPOSITION FOR IMPROVING SKIN CONDITION
WO2008027580A2 (en) * 2006-09-01 2008-03-06 University Of Louisville PARTICULATE β-GLUCAN COMPOSITIONS FOR REGULATING DENDRITIC CELLS
US20080063650A1 (en) * 2006-09-01 2008-03-13 Jun Yan mCRP antagonists and their uses
WO2008032134A1 (es) * 2006-09-11 2008-03-20 Compana Nacional De Levaduras Levapan S.A. Proceso para la obtencion de glucan de levadura por autolisis de celulas de levadura saccharomyces cerevisiae de panaderia
TR201807223T4 (tr) 2007-09-27 2018-06-21 Biothera Inc Üst solunum yolu enfeksiyonu semptomları ve psikolojik iyilik için b-glükan tedavisi.
US20100267661A1 (en) * 2009-03-17 2010-10-21 Immudyne, Inc. Beta glucans and methods of use thereof
FR2949684B1 (fr) * 2009-09-04 2011-12-16 Silab Sa Principe actif issu de candida saitoana et utilisation cosmetique pour la detoxification des cellules de la peau
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
EP2694030A2 (en) 2011-03-04 2014-02-12 Sana Pharma AS Cosmetic formulations
WO2013006795A2 (en) 2011-07-07 2013-01-10 Humanitas International Foundation Antiviral compositions and methods of their use
WO2014008353A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
JP6122605B2 (ja) * 2012-10-16 2017-04-26 株式会社 資生堂 美白方法及びメラニン合成抑制剤のスクリーニング方法
US20150366238A1 (en) 2013-02-21 2015-12-24 Direvo Industrial Biotechnology Gmbh Prebiotic animal feed product
WO2016007876A1 (en) 2014-07-10 2016-01-14 Biothera, Inc. Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment
EP3215163B1 (en) 2014-11-06 2021-03-10 Biothera, Inc. Beta-glucan methods and compositions that affect the tumor microenvironment
WO2018156888A1 (en) 2017-02-24 2018-08-30 Biothera Pharmaceuticals, Inc. Beta glucan immunopharmacodynamics
AU2018347551B2 (en) * 2017-10-13 2023-09-14 Nutrition & Biosciences USA 4, Inc. Flowable bulk granular polysaccharide
CN111699246A (zh) * 2018-02-09 2020-09-22 雷碧尔制药有限责任公司 粒子、含粒子组合物以及粒子的制造方法
WO2021006684A1 (ko) * 2019-07-10 2021-01-14 한국식품연구원 피부암 억제 활성이 우수한 효모 초음파 추출물의 제조방법 및 상기 방법으로 제조된 효모 초음파 추출물을 함유한 피부암 억제용 조성물
KR20220025752A (ko) * 2020-02-19 2022-03-03 케민 인더스트리즈, 인코포레이티드 용해성 베타 글루칸의 조성물 및 관련 방법
CO2020004754A1 (es) 2020-04-17 2020-10-20 Compania Nac De Levaduras Levapan S A Proceso de obtención de β-glucano a partir de levadura de panadería
KR20240038929A (ko) 2021-05-26 2024-03-26 뉴트라맥스 래보러토리즈, 인크. 설포라판 또는 설포라판 전구체 및 모링가 식물 성분을 포함하는 조성물
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
CN113576956A (zh) * 2021-08-18 2021-11-02 广州暨创生物医药研究院有限公司 一种抗衰祛皱的酵母提取物的制备方法及其应用
WO2023119195A2 (en) * 2021-12-21 2023-06-29 Universidade Católica Portuguesa - Ucp YEAST β-GLUCAN EMULSION, METHODS AND USES THEREOF

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138479A (en) * 1975-11-07 1979-02-06 Bayer Aktiengesellschaft Process for the preparation of immunopotentiating agents from components of yeast cell wall material
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
FR2477416A1 (fr) * 1980-03-10 1981-09-11 Unicler Utilisation de hansenula ou d'extraits de hansenula, comme medicament
FR2486400B1 (fr) * 1980-07-09 1986-05-30 Univablot Medicaments a base de levures ou de leurs extraits insolubles
JPS59210901A (ja) * 1983-05-17 1984-11-29 Nippon Kinoko Kenkyusho プロテオグルカン及びそれからなる抗ガン剤
CH654210A5 (it) * 1983-05-20 1986-02-14 Hasunor Ag Procedimento per ottenere preparati metabolicamente attivi ottenuti da lievito di qualsiasi tipo.
SE466289B (sv) * 1984-09-19 1992-01-27 James Hoffman Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
US5037972A (en) * 1984-11-28 1991-08-06 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4810646A (en) * 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5082936A (en) * 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
DE3721190C1 (de) * 1987-06-26 1989-02-02 Heyl Chem Pharm Kosmetisches Mittel
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2609397B1 (fr) * 1988-02-23 1991-12-13 Serobiologiques Lab Sa Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique

Also Published As

Publication number Publication date
EP0500718A4 (en) 1994-09-14
CA2072145C (en) 1997-09-16
CA2072145A1 (en) 1991-05-10
EP0500718A1 (en) 1992-09-02
US5223491A (en) 1993-06-29
US5397773A (en) 1995-03-14
EP0500718B1 (en) 1997-01-29
WO1991007091A1 (en) 1991-05-30
DE69029860T2 (de) 1997-06-12
JPH05504131A (ja) 1993-07-01
DE69029860D1 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
ES2097764T3 (es) Extracto de levadura insoluble.
DE68910051D1 (de) Verfahren zur herstellung von aloe-erzeugnissen.
PT87394A (pt) Process for plant tissue transformation
AU6885891A (en) Method of manufacture of a material for osteoplasty from a natural bone tissu and material obtained thereby
BR9106205A (pt) Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento
ES8600613A1 (es) Procedimiento para el tratamiento de tejidos corporales
ES2160116T3 (es) Modelo de equivalente de cornea producido in vitro.
CA2238011A1 (en) A biologic material comprising an efficient culture of bone marrow stem cells partially or completely differentiated into connective tissue cells and a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid derivative
PT93996A (pt) Processo para a producao de factor de crescimento de celulas endoteliais vasculares e de dna codificador do mesmo
NO179505C (no) Fremgangsmåte for fremstilling av en syntetisk ekstracellulær matriks
EP0965310A4 (en) ARTIFICIAL BLOOD VESSEL
PL337019A1 (en) Peptide-coated implants and method of obtaining them
ES8704546A1 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
FR2699408B1 (fr) Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
MY113045A (en) Waste treatment plant and process
ES2140430T3 (es) Procedimiento para aumentar el brillo del cabello y para reparar el cabello dañado por productos alcalinos.
ES2055743T3 (es) Procedimiento de reticulacion del colageno por introduccion de grupos azidas asi como los tejidos y biomateriales obtenidos por aplicacion del procedimiento.
PT96231A (pt) Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao
GR852771B (es)
DE3850655D1 (de) Verfahren zur Behandlung von Implantatmaterial und Implantat.
ATE136464T1 (de) Stimulator von vaskulären endothelzellen und seine verwendung
FR2687544B1 (fr) Pain eleve aux ferments naturels de fruits et notamment de raisin, et son procede de fabrication.
FR2527779B1 (fr) Materiau simulateur du tissu osseux, son procede de preparation et ses utilisations
ATE515947T1 (de) Verfahren zur herstellung von abgeschwächten starterkulturen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500718

Country of ref document: ES